为进一步提高中晚期肝癌患者的生存率。方法对１５例原发性肝癌患者进行肝动脉化疗栓塞（ＴＡＥ）和局部酒精注射（ＰＥＩＴ）双介入疗法。结果１２例巨块型肝癌中１０例肿块缩小明显（２６．２％～７１．４％），２例缩小不明显（４．３％～８．３％），平均缩小３３．２％，３例弥漫性肝癌的肝脏有回缩。ＡＦＰ有不同程度降低，生在期延长，６个月生存率为１００％，１年达８０％，２年为１３．３％，平均为１６．７个月。结论双介入疗法较单用ＴＡＥ治疗能延长病人生存时嵓 To further improve the survival rate of patients with advanced liver cancer. Methods Twenty-five patients with primary liver cancer underwent dual-interventional hepatic arterial chemoembolization (TAE) and local alcohol injection (PEIT). Results The mass of 10 cases of massive hepatocellular carcinoma was significantly reduced (26.2% to 71.4%) in 12 cases of massive hepatocellular carcinoma, and 2 cases were not significantly reduced (4.3% to 8.3%), with an average reduction of 33.2%. 3 The liver of patients with diffuse liver cancer retracted. AFP has different degrees of reduction, prolonged life, 6-month survival rate of 100%, 1 year to 80%, 2 years to 13.3%, an average of 16.7 months. Conclusion Double interventional therapy can prolong the survival of patients compared with TAE alone.